Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zaman, Mohd Saif ^a   Thamminana, Sobha ^a   Shahryari, Varahram ^a   Chiyomaru, Takeshi ^a   Deng, Guoren ^a   Saini, Sharanjot ^a   Majid, Shahana ^a   Fukuhara, Shinichiro ^a   Chang, Inik ^a   Arora, Sumit ^a   Hirata, Hiroshi ^a   Ueno, Koji ^a   Singh, Kamaldeep ^a   Tanaka, Yuichiro ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 32; MICRORNA; MICRORNA 23B 3P; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; KIDNEY CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE;

EID: 84870021606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050203     Document Type: Article

References (29)

1. Bhatt K, Mi QS, Dong Z, (2011) microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602-610.
2. Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, et al. (2009) MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50: 575-584.
3. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
4. Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, et al. (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23: 1229-1234.
5. Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, et al. (2010) miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29: 4914-4924.
6. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, et al. (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16: 206-216.
7. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, et al. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458: 762-765.
8. Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, et al. (2012) Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene. Jan 9. doi: 10.1038/onc.2011.583 [Epub ahead of print].
9. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, et al. (2009) MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276: 2966-2982.
10. Zhang H, Hao Y, Yang J, Zhou Y, Li J, et al. (2011) Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2: 554.
11. Weng L, Brown J, Eng C, (2001) PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and-independent pathways. Hum Mol Genet 10: 237-242.
12. Qian J, Ling S, Castillo AC, Long B, Birnbaum Y, et al. (2012) Regulation of Phosphatase and Tensin Homolog on Chromosome Ten (PTEN) in Response to Hypoxia. Am J Physiol Heart Circ Physiol. 302(9): H1806-17. Epub 2012 Feb 24.
13. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, et al. (2004) The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37: 449-471.
14. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39.
15. Chalhoub N, Baker SJ, (2009) PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150.
16. Sorrentino C, Di Carlo E, (2009) Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 180: 769-779.
17. Lee S, Kim JH, Kim H, Kang JW, Kim SH, et al. (2011) Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 132: 410-420.
18. Seo EH, Kang J, Kim KH, Cho MC, Lee S, et al. (2008) Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 18: 1606-1612.
19. Yagi Y, Andoh A, Imaeda H, Aomatsu T, Ohsaki R, et al. (2011) Interleukin-32alpha expression in human colonic subepithelial myofibroblasts. Int J Mol Med 27: 263-268.
20. Ko NY, Mun SH, Lee SH, Kim JW, Kim do K, et al. (2011) Interleukin-32alpha production is regulated by MyD88-dependent and independent pathways in IL-1beta-stimulated human alveolar epithelial cells. Immunobiology 216: 32-40.
21. Nishida A, Andoh A, Inatomi O, Fujiyama Y, (2009) Interleukin-32 expression in the pancreas. J Biol Chem 284: 17868-17876.
22. Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A, et al. (2008) Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 294: G831-838.
23. Magee PJ, Rowland IR, (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91: 513-531.
24. Bektic J, Guggenberger R, Eder IE, Pelzer AE, Berger AP, et al. (2005) Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer 4: 124-129.
25. Hunter T, (1987) A thousand and one protein kinases. Cell 50: 823-829.
26. Ullrich A, Schlessinger J, (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212.
27. Zava DT, Duwe G, (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40.
28. Hillman GG, Wang Y, Che M, Raffoul JJ, Yudelev M, et al. (2007) Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer 7: 4.
29. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, et al. (2012) Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One 7: e31060 Epub 2012 Feb 8.